MyCEI Login


2022 Annual NYS Hepatitis C & Drug User Health Conference-Day1


Published Date: 12/02/2022

Expiration Date: 09/21/2025

CE Credit: CME:3CNE: 3CPE: 3


This two-part training series from the 2022 annual New York State Hepatitis C and Drug User Health conference overviews best practices and new approaches in hepatitis C and drug user health care in New York State. Part one includes the following five sessions:

  • On Goofballs and Speedballs, Polysubstance Use in the Age of Fentanyls
  • Advances in Overdose Prevention and Harm Reduction in New York State
  • Harm Reduction and Mental Health Care in People who Use Drugs
  • Best Practices for Low Threshold Buprenorphine
  • Resistance Testing in Hepatitis C Treatment, A Case-Based Discussion


Effective June 27, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for practitioners who are applying for or renewing their DEA license. This 1-hour ACCME-accredited course meets the DEA/SAMHSA requirement.


Dan Ciccarone,MD, MPH

Dr. Dan Ciccarone, MD, MPH is the Justine Miner Professor in Addiction Medicine, in the department of Family and Community Medicine, at UCSF. He has been principal or co-investigator on numerous NIH sponsored public health research projects including his current Synthetics in Combination (SYNC) study. He is a recognized international scholar on the medical, public health and public policy dimensions of substance use, risk and consequences. He is Associate Editor for the International Journal of Drug Policy and recently edited an IJDP special issue on the “triple wave crisis” of opioids, heroin and fentanyl in the US. He consults for numerous private and public entities including the ONDCP, CDC and FDA. 

Brandon Marshall ,PhD

Brandon Marshall, PhD is a professor of epidemiology at the Brown University School of Public Health. He is also founding director of the People, Place & Health Collective at Brown University. Dr. Marshall’s research focuses on substance use epidemiology, with a specific emphasis on harm reduction and overdose prevention. He is passionate about conducting research that improves the health and well-being of people who use drugs.

Sam Rivera,

Sam Rivera has over 29 years of progressive experience in social services. His primary focus of expertise lies in Criminal Justice/Reentry, HIV/AIDS, Harm Reduction, Addiction/Recovery, and Mental Health. He currently serves as the Executive Director of New York Harm Reduction Educators and Washington Heights Corner Project, two merging harm reduction organizations that provide services to active drug users and sex workers in Northern Manhattan and The South Bronx, many of whom are low-income or homeless as well as of color and LGBTQ. He brings to this role his several decades of cutting-edge service provision experience and a commitment to social justice. He has dedicated his professional career to ameliorating the harms associated with the War on Drugs, racism/sexism, structural inequality, and mass incarceration and will continue to work to end systemic as well as systematic barriers to populations that are most vulnerable.

Kailin See,

Kailin is proud to be the Senior Director of Programs for both the Washington Heights CORNER Project and the New York Harm Reduction Educations serving Washington Heights, East Harlem and the Bronx in New York City. She was the program and development lead for the historic opening of the first two sanctioned overdose prevention centers in the United States.

Before moving to New York in 2016, Kailin worked in Vancouver, Canada developing and operating innovative, award winning drug user-focused programs including the Drug User's Resource Center (DURC) which employed 150 active substance users and saw 1000 member visits a day. Beyond DURC, Kailin developed Canada’s first street-entrenched Managed Alcohol Program and an Alcohol Exchange for illicit alcohol consumers, a first in the world. Her many years working to improve the lived of people who use drugs has afforded her the opportunity to garner experience across multiple sectors including housing/shelter for active substance users, community based detox and treatment, social enterprise, indigenous-directed care and cultural programming, drug policy reform, advocacy and safe consumption. 

Clara Cardelle,

Clara first learned about harm reduction in 2005 after completing a residential treatment program following 18 years of crack cocaine use. She visited the Washington Heights CORNER Project on the recommendation of her peers in the neighborhood and quickly became a participant of the program. Clara began using heroin in 2012 and credits the Washington Heights CORNER Project for keeping her safe and healthy throughout her use. She is a fierce advocate for the rights of people who use drugs and has been to Albany and Washington many times fighting for policy change and meaningful action to redress the harms of the war on drug users. Clara has been an invaluable member of the WHCP staff team for nearly 9 years serving as a peer, outreach specialist and now as the Senior Harm Reduction Associate. Harm Reduction is her passion.

Today she is proud to say she works in and uses the first overdose prevention center in the USA.

Linda Wang,MDLinda Wang is a Clinical Instructor in the Division of General Internal Medicine at Mount Sinai. She received her undergraduate degree from Swarthmore College and her medical degree from the Icahn School of Medicine at Mount Sinai. She completed internal medicine residency and chief residency in the Primary Care and Social Medicine Program at Montefiore Medical Center in the Bronx. She is a board-certified internist practicing general internal medicine at Internal Medicine Associates (IMA). Her clinical interests include preventive health, chronic disease management, primary care-based buprenorphine treatment, comprehensive and stigma-free care for individuals with substance use, and resident education.
Daniel Suter,MD

Daniel Suter, MD was born and raised in Pittsburgh, Pennsylvania before attending college at the University of Toronto and working for a period in Montreal. He returned to the University of Pittsburgh for Medical School and completed his Psychiatry Residency at the Icahn School of Medicine at Mount Sinai in NYC. He subsequently completed an Addiction Psychiatry Fellowship through the Mount Sinai Addiction Institute. Currently he is an attending on the inpatient detox/rehab and consultation services at the Addiction Institute, where he is involved in teaching trainees and clinical care. 

Andrea Jakubowski,MD, MS

Andrea Jakubowsk, MD, MS vi is an Assistant Professor and Internist at Montefiore Medical Center's Comprehensive Care Center in the Bronx. She received her medical degree from the Icahn School of Medicine at Mount Sinai.

Douglas T. Dieterich,MDDouglass Dieterich, MD is currently Director for the Institute of Liver Medicine at the Mount Sinai Health System and Professor of Medicine in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai, New York, NY. Douglas T. Dieterich graduated from Yale University in New Haven, CT and received his Doctorate of Medicine from New York University of Medicine in NY. He completed his internship and residency in Internal Medicine at the Bellevue Hospital Center in New York, NY where he was also a fellow in the Division of Gastroenterology. Dr. Dieterich is an investigator for several ongoing studies evaluating the safety and efficacy of various antiviral treatment regimens for chronic hepatitis B & C, NASH and PSC.

Learning Objectives

  • Discuss clinical updates and New York State guidelines related to hepatitis C and drug user health.
  • Describe methods to increase capacity to provide high-quality hepatitis C care and treatment.
  • Describe methods to increase capacity to provide high-quality drug user health care.
  • Identify and disseminate current best practices for hepatitis C and drug user health among New York State-based medical providers.

Continuing Education Credit Information